FDA approves cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation
- Details
- Category: FDA

FDA approves first over-the-counter naloxone nasal spray
- Details
- Category: FDA

FDA grants Accelerated Approval for Alzheimer's disease treatment
- Details
- Category: FDA

FDA approves new HIV drug for adults with limited treatment options
- Details
- Category: FDA

FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
- Details
- Category: FDA

FDA approves first gene therapy to treat adults with Hemophilia B
- Details
- Category: FDA

FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
- Details
- Category: FDA

More Pharma News ...
- FDA approves first systemic treatment for alopecia areata
- FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
- FDA limits use of Janssen COVID-19 vaccine to certain individuals
- EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
- FDA approves first generic of Symbicort to treat asthma and COPD
- FDA approves treatment for wider range of patients with heart failure
- EMA: Human medicines highlights of 2021